Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

160
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
160
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

164
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
164
Tumor Immunotherapy01:27

Tumor Immunotherapy

2.5K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fabrication of TiO<sub>2</sub> Nanoparticles with High Colloidal Stability through Surface Modification via Biocompatible Block Copolymers and Heating.

Langmuir : the ACS journal of surfaces and colloids·2026
Same author

Domino Polymerization for the Synthesis of Reductively Degradable Poly(disulfide)s With Arbitrary Side-Chain Structures.

Angewandte Chemie (International ed. in English)·2026
Same author

Iatrogenic Right Ventricular Perforation Following an Endomyocardial Biopsy for Fulminant Myocarditis.

Cureus·2026
Same author

Interfacial photocycloaddition polymerization: a synthetic approach for structurally functionalized degradable polymer particles from naturally derived monomers.

Chemical science·2026
Same author

Construction of Robust Cross-Linked Polymer Shells in Interfacial Photocycloaddition Polymerization: Trifunctional vs Tetrafunctional Monomers.

Langmuir : the ACS journal of surfaces and colloids·2025
Same author

Calcium Ion-Induced Self-Assembly of Carboxylated Polyallylamine-<i>graft</i>-Poly(Ethylene Glycol) in an Aqueous Medium.

Polymers·2025

Related Experiment Video

Updated: May 4, 2026

Using In Vitro Live-cell Imaging to Explore Chemotherapeutics Delivered by Lipid-based Nanoparticles
10:26

Using In Vitro Live-cell Imaging to Explore Chemotherapeutics Delivered by Lipid-based Nanoparticles

Published on: November 1, 2017

10.6K

Dextran derivative-based pH-sensitive liposomes for cancer immunotherapy.

Eiji Yuba1, Naoki Tajima1, Yuta Yoshizaki1

  • 1Department of Applied Chemistry, Graduate School of Engineering, Osaka Prefecture University, 1-1 Gakuen-cho, Naka-ku, Sakai, Osaka 599-8531, Japan.

Biomaterials
|January 11, 2014
PubMed
Summary

Novel pH-sensitive dextran derivatives (MGlu-Dex) create liposomes that efficiently deliver antigens to dendritic cells. This approach enhances immune responses and suppresses tumor growth, showing promise for cancer immunotherapy.

Keywords:
Cancer immunotherapyCellular immunityCytoplasmic deliveryDendritic cellDextranpH-Sensitive liposome

More Related Videos

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles
09:56

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles

Published on: August 2, 2016

14.2K
Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells
09:34

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells

Published on: February 9, 2019

8.4K

Related Experiment Videos

Last Updated: May 4, 2026

Using In Vitro Live-cell Imaging to Explore Chemotherapeutics Delivered by Lipid-based Nanoparticles
10:26

Using In Vitro Live-cell Imaging to Explore Chemotherapeutics Delivered by Lipid-based Nanoparticles

Published on: November 1, 2017

10.6K
Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles
09:56

Preparation and Characterization of Lipophilic Doxorubicin Pro-drug Micelles

Published on: August 2, 2016

14.2K
Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells
09:34

Uptake of New Lipid-coated Nanoparticles Containing Falcarindiol by Human Mesenchymal Stem Cells

Published on: February 9, 2019

8.4K

Area of Science:

  • Biomaterials Science
  • Immunology
  • Nanotechnology

Background:

  • Developing effective antigen delivery systems is crucial for enhancing immunotherapies.
  • Liposomes are widely explored for drug and antigen delivery due to their biocompatibility.
  • Modulating liposome properties for targeted delivery and controlled release remains a key challenge.

Purpose of the Study:

  • To synthesize and characterize pH-sensitive dextran derivatives (MGlu-Dex).
  • To engineer MGlu-Dex-modified liposomes for enhanced antigen delivery and immunogenicity.
  • To evaluate the therapeutic efficacy of these liposomes in a preclinical cancer model.

Main Methods:

  • Dextran was reacted with 3-methyl-glutaric anhydride to create MGlu-Dex.
  • Egg yolk phosphatidylcholine liposomes were surface-modified with MGlu-Dex.
  • pH-sensitivity, liposome uptake by dendritic cells, and ovalbumin (OVA) delivery were assessed.
  • Antigen-specific humoral and cellular immunity, and tumor suppression were evaluated in vivo.

Main Results:

  • MGlu-Dex exhibited pH-dependent hydrophilic-to-hydrophobic transitions.
  • MGlu-Dex-modified liposomes demonstrated stability at neutral pH and destabilization at acidic pH.
  • These liposomes were efficiently internalized by dendritic cells, delivering entrapped OVA to the cytosol.
  • Subcutaneous administration induced stronger antigen-specific immunity and significantly suppressed E.G7-OVA tumor growth, extending survival.

Conclusions:

  • MGlu-Dex-modified liposomes represent a promising pH-sensitive antigen delivery platform.
  • This system enhances antigen presentation and stimulates robust anti-tumor immune responses.
  • The findings suggest potential for developing safe and potent cancer immunotherapies.